Pneumococcal conjugate vaccines for preventing acute otitis media in children

Joline LH Sévaux; Roderick P Venekamp; Vittoria Lutje; Eelko Hak; Anne Schilder; Elisabeth Sanders; Roger Damoiseaux

doi:10.1002/14651858.cd001480.pub6

Pneumococcal conjugate vaccines for preventing acute otitis media in children

Joline LH Sévaux, Roderick P Venekamp, Vittoria Lutje, Eelko Hak, Anne Schilder, Elisabeth Sanders, Roger Damoiseaux

Clinical Sciences

Liverpool School of Tropical Medicine

Research output: Contribution to journal › Review article › peer-review

16 Citations (Scopus)

Abstract

Background

Prior to introducing pneumococcal conjugate vaccines (PCVs), Streptococcus pneumoniae was most commonly isolated from the middle ear fluid of children with acute otitis media (AOM). Reducing nasopharyngeal colonisation of this bacterium by PCVs may lead to a decline in AOM. The effects of PCVs deserve ongoing monitoring since studies from the post‐PCV era report a shift in causative otopathogens towards non‐vaccine serotypes and other bacteria. This updated Cochrane Review was first published in 2002 and updated in 2004, 2009, 2014, and 2019.

Original language	English
Article number	CD001480
Pages (from-to)	CD001480
Journal	Cochrane Database of Systematic Reviews
Volume	2020
Issue number	11
DOIs	https://doi.org/10.1002/14651858.cd001480.pub6
Publication status	Published - 24 Nov 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/14651858.cd001480.pub6

S-vaux et al-2020-Cochrane Database of Systematic ReviewsFinal published version, 678 KB

Cite this

@article{ef9d1baf01584af1b35fc37c8e0fdfbc,

title = "Pneumococcal conjugate vaccines for preventing acute otitis media in children",

abstract = "BackgroundPrior to introducing pneumococcal conjugate vaccines (PCVs), Streptococcus pneumoniae was most commonly isolated from the middle ear fluid of children with acute otitis media (AOM). Reducing nasopharyngeal colonisation of this bacterium by PCVs may lead to a decline in AOM. The effects of PCVs deserve ongoing monitoring since studies from the post‐PCV era report a shift in causative otopathogens towards non‐vaccine serotypes and other bacteria. This updated Cochrane Review was first published in 2002 and updated in 2004, 2009, 2014, and 2019.",

author = "S{\'e}vaux, \{Joline LH\} and Venekamp, \{Roderick P\} and Vittoria Lutje and Eelko Hak and Anne Schilder and Elisabeth Sanders and Roger Damoiseaux",

year = "2020",

month = nov,

day = "24",

doi = "10.1002/14651858.cd001480.pub6",

language = "English",

volume = "2020",

pages = "CD001480",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "11",

}

TY - JOUR

T1 - Pneumococcal conjugate vaccines for preventing acute otitis media in children

AU - Sévaux, Joline LH

AU - Venekamp, Roderick P

AU - Lutje, Vittoria

AU - Hak, Eelko

AU - Schilder, Anne

AU - Sanders, Elisabeth

AU - Damoiseaux, Roger

PY - 2020/11/24

Y1 - 2020/11/24

N2 - BackgroundPrior to introducing pneumococcal conjugate vaccines (PCVs), Streptococcus pneumoniae was most commonly isolated from the middle ear fluid of children with acute otitis media (AOM). Reducing nasopharyngeal colonisation of this bacterium by PCVs may lead to a decline in AOM. The effects of PCVs deserve ongoing monitoring since studies from the post‐PCV era report a shift in causative otopathogens towards non‐vaccine serotypes and other bacteria. This updated Cochrane Review was first published in 2002 and updated in 2004, 2009, 2014, and 2019.

AB - BackgroundPrior to introducing pneumococcal conjugate vaccines (PCVs), Streptococcus pneumoniae was most commonly isolated from the middle ear fluid of children with acute otitis media (AOM). Reducing nasopharyngeal colonisation of this bacterium by PCVs may lead to a decline in AOM. The effects of PCVs deserve ongoing monitoring since studies from the post‐PCV era report a shift in causative otopathogens towards non‐vaccine serotypes and other bacteria. This updated Cochrane Review was first published in 2002 and updated in 2004, 2009, 2014, and 2019.

U2 - 10.1002/14651858.cd001480.pub6

DO - 10.1002/14651858.cd001480.pub6

M3 - Review article

SN - 1465-1858

VL - 2020

SP - CD001480

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 11

M1 - CD001480

ER -

Pneumococcal conjugate vaccines for preventing acute otitis media in children

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this